Health
BioNTech Stock Pops Ahead Of Earnings; But Can Its Vaccine Tackle Delta? – Investor’s Business Daily
BioNTech stock popped Monday after the Covid-vaccine maker said it would announce second-quarter earnings results in a week.
BioNTech stock popped Monday after the Covid vaccine maker said it would announce second-quarter earnings results in a week.
XAnalysts polled by FactSet expect BioNTech (BNTX) to report adjusted earnings of $8.94 per share and almost $3.86 billion in sales….
Continue Reading
-
General16 hours agoVictorian school teacher charged with soliciting child abuse material
-
Business24 hours agoHere’s what analysts expect for the BHP share price in the coming year
-
General7 hours agoAustralia loses ODI series to South Africa with defeat in second game in Mackay
-
General24 hours agoPatients speak out after Brisbane doctor accused of ‘excessive’ pap smears, kissing woman on lips